Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral antibiotics for prevention of anastomotic leak after elective colorectal resection
ACTRN12622000285752Phase 2Not yet recruiting
- Sponsor
- Mr Asiri Arachchi
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of neomycin and metronidazole in anastomotic dehiscence (AD) and surgical site infection (SSI) (2 arms), sponsored by Mr Asiri Arachchi. Primary endpoints: Incidence of any anastomotic leak and Incisional surgical site infection. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
neomycinmetronidazole
03
Conditions
anastomotic dehiscence (AD)surgical site infection (SSI)
Beyond the preview
Go deeper on ACTRN12622000285752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000285752.